Pharmasset to collaborate on a safer, simpler hepatitis C drug; CytRx touts cancer drug results; Regado raises $11.6M;

@FierceBiotech: J&J gets FDA green light for blockbuster blood thinner Xarelto. News | Follow @FierceBiotech

@JohnCFierce: Totting up the $$ in Rib-X antibacterial pact with Sanofi: $10M upfront, $9M for research and $186M in milestones per. Item | Follow @JohnCFierce

> Pharmasset has forged a collaboration pact with Tibotec Pharmaceuticals, agreeing to evaluate the safety and efficacy of a combined product for hepatitis C in a mid-stage study. Pharmasset release

> CytRx reports that its experimental cancer treatment INNO-206  demonstrated its ability to safely deliver high doses of a chemotherapy. Report

> Regado Biosciences has raised $11.6 million, much of which will be used to advance an experimental anticoagulant for use during surgeries. Regado's staff is split between New Jersey and North Carolina. Report

> Germany's Antisense Pharma has completed an 8 million euro round of financing. Antisense release

> The Baltimore Sun takes a look at the new biotech strategy now in place in Maryland. State economic development officials are touting their talent pool of company execs, consultants and academics as a resource for growing biotech companies. Story

> Bioniche has bought the Australia's Plasvaac, which manufactures blood-plasma products for animals. Story

Pharma News

@FiercePharma: Study: Pfizer's Chantix raises heart risks 72%. Story | Follow @FiercePharma

> Pfizer's Lyrica performs in Japanese fibromyalgia trial. Item

> AZ loses round in Lucentis patent fight. Report

> EU watchdogs flag fewer 'problem' patent deals. Article

> FDA warns Cadila, slaps ban on Dr. Reddy's. Story

> GSK launches next revamp of sales-rep pay. News

> Russian police search Novartis, Teva in distribution probe. Report

Medical Device News

> C.R. Bard to pay $184M to end Davol suits. Story

> Synthes vet tapped as next Nobel Biocare chair. News

> MyoPowers closes $19M Series B round. Report

> Analyst: Infuse fallout could lead to Medtronic selling spine biz. Item

Drug Delivery News

> DNA cages can unleash meds inside cells. Article

> All eyes on pSivida for back-of-the-eye drug delivery. Report

> Europe OKs Merck Serono's prefilled IVF pen injector. Piece

And Finally... Investigators say that a natural form of vitamin E can guard against stroke damage. Report

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

Zydus Cadila has completed a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 .